Alzheimer’s disease (AD) is characterized by deposition of the amyloid beta (Ab) peptide in the brain, an event which frequently but not universally correlates with nerve cell death. Although most nerve cells die in response to Ab, small populations of cells are able to survive by becoming resistant to Ab toxicity. Understanding the mechanisms by which cells become resistant to Ab may reveal novel treatments for AD. Interestingly, nerve cell lines selected for resistance against Ab exhibit increased glucose uptake and glycolytic flux. Here I show that these metabolic changes are mediated through an upregulation of pyruvate dehydrogenase kinase 1 (PDK1) and increased lactate dehydrogenase A (LDHA) activity. These metabolic alterations in Ab ...
This research is supported by Alzheimer's Research UK, the Wellcome Trust and the Biotechnology and ...
Epidemiological and biochemical studies show that the sporadic forms of Alzheimer's disease (AD) are...
Alzheimer’s disease (hereafter AD) is a progressive neurodegenerative disorder that affects cognitiv...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is cl...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer\u27s disease (AD) is...
Background: Aerobic glycolysis promotes resistance against Aβ toxicity. Results: Increased LDHA and ...
Alzheimer’s disease is a progressive, neurodegenerative disorder characterized by the accumulation o...
AbstractIt is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by amyloid plaques that are co...
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that has become the sixth leadi...
Alzheimer's disease (AD) and cancer proceed via one or more common molecular mechanisms: a metabolic...
Synaptic degeneration and death of nerve cells are defining features of Alzheimer's disease (AD) and...
Epidemiological and biochemical studies show that the sporadic forms of Alzheimer's disease (AD) are...
Evidence suggests that amyloid-beta (Aβ) protein is a key factor in the pathogenesis of Alzheimer's ...
Mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD) and increased productio...
This research is supported by Alzheimer's Research UK, the Wellcome Trust and the Biotechnology and ...
Epidemiological and biochemical studies show that the sporadic forms of Alzheimer's disease (AD) are...
Alzheimer’s disease (hereafter AD) is a progressive neurodegenerative disorder that affects cognitiv...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer's disease (AD) is cl...
Amyloid beta (Aβ) peptide accumulation in the brains of patients with Alzheimer\u27s disease (AD) is...
Background: Aerobic glycolysis promotes resistance against Aβ toxicity. Results: Increased LDHA and ...
Alzheimer’s disease is a progressive, neurodegenerative disorder characterized by the accumulation o...
AbstractIt is frequently argued that both amyloid beta (Aβ) and oxidative stress are involved in the...
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by amyloid plaques that are co...
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that has become the sixth leadi...
Alzheimer's disease (AD) and cancer proceed via one or more common molecular mechanisms: a metabolic...
Synaptic degeneration and death of nerve cells are defining features of Alzheimer's disease (AD) and...
Epidemiological and biochemical studies show that the sporadic forms of Alzheimer's disease (AD) are...
Evidence suggests that amyloid-beta (Aβ) protein is a key factor in the pathogenesis of Alzheimer's ...
Mitochondrial dysfunction is a prominent feature of Alzheimer's disease (AD) and increased productio...
This research is supported by Alzheimer's Research UK, the Wellcome Trust and the Biotechnology and ...
Epidemiological and biochemical studies show that the sporadic forms of Alzheimer's disease (AD) are...
Alzheimer’s disease (hereafter AD) is a progressive neurodegenerative disorder that affects cognitiv...